Xspire Pharma, LLC

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Xspire Pharma, LLC
Quantité totale PI 18
Rang # Quantité totale PI 85 194
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 712 852
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

13 3
0 2
0 0
0
 
Dernier brevet 2017 - Immediate-release tablet formula...
Premier brevet 2001 - Nor-seco himbacine derivatives u...
Dernière marque 2019 - XSPIRE PHARMA
Première marque 2013 - ZONTIVITY

Industrie (Classification de Nice)

Derniers inventions, produits et services

2019 P/S Pharmaceutical preparations for the treatment of cardiovascular, dermatological, gastrointestinal...
2018 P/S A prescription pharmaceutical with a corticosteroid as its primary ingredient for the treatment o...
P/S Pharmaceutical preparations, namely, prescription drugs for treating pain and inflammation; Pharm...
2016 Invention Immediate-release tablet formulations of a thrombin receptor antagonist. Immediate-release formu...
2014 Invention Co-crystal of the par-1 receptor antagonists vorapaxar and aspirin. This invention relates to a c...
P/S Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disor...
2013 P/S Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders.
2012 Invention Exo- and diastereo-selective synthesis of himbacine analogs. This application discloses a novel p...
Invention Exo-selective synthesis of himbacine analogs. This application discloses a novel process for the ...
2011 Invention Exo- and diastereo- selective synthesis of himbacine analogs. This application discloses a novel ...
2010 Invention Active metabolite of a thrombin receptor antagonist. Disclosed herein is an active metabolite (“M...
Invention Synthesis of diethyl{[5-(3-fluorophenyl)-pyridine-2yl]methyl}phosphonate. This application disclo...
2009 Invention Exo- and diastereo-selective syntheses of himbacine analogs. This application discloses a novel p...
Invention Synthesis of himbacine analogs. The present invention relates to an improved process for preparin...
2007 Invention Thrombin receptor antagonists. Heterocyclic-substituted tricyclics of the formula wherein the r...
2006 Invention Exo- and diastereo- selective syntheses of himbacine analogs. This application discloses a novel ...
2004 Invention Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist. A crystalline polymo...
2003 Invention Thrombin receptor antagonists. A series of compounds represented by the structural formulas and...
Invention Thrombin receptor antagonists. Also disclosed are pharmaceutical compositions containing said co...
Invention Thrombin receptor antagonists. Heterocyclic-substituted tricyclics of the formula B is a bond, a...
2001 Invention Nor-seco himbacine derivatives useful as thrombin receptor antagonists. Heterocyclic-substituted ...